Down-regulation of T cell responses to AChR and reversal of EAMG manifestations in mice by a dual altered peptide ligand via induction of CD4+CD25+ regulatory cells-Reference-Cited by-同舟云学术

Down-regulation of T cell responses to AChR and reversal of EAMG manifestations in mice by a dual altered peptide ligand via induction of CD4+CD25+ regulatory cells

Published:2006-08 Issue:1-2 Volume:177 Page:63-75
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Aruna Badiga Venkata,Sela Michael,Mozes Edna

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference46 articles.

1. Suppression of rnyasthenogenic responses of a T cell line by a dual altered peptide ligand by induction of CD4(+)CD25(+) regulatory cells;Aruna;Proc. Natl. Acad. Sci. U. S. A.,2005

2. Analysis of the biological functions and fine specificity of (T,G)-A-L specific T cell clones;Axelrod;Immunobiology,1986

3. Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis;Balandina;Blood,2005

4. Down-regulation of myasthenogenic T cell responses by a dual altered peptide ligand via CD4(+)CD25(+)-regulated events leading to apoptosis;Ben-David;Proc. Natl. Acad. Sci. U. S. A.,2005

5. In vitro proliferative responses and antibody titters specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes;Brocke;J. Clin. Invest.,1988

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management;Frontiers in Neurology;2020-11-30

2. Transgenic rice seeds expressing altered peptide ligands against the M3 muscarinic acetylcholine receptor suppress experimental sialadenitis-like Sjögren’s syndrome;Modern Rheumatology;2019-09-18

3. A Sensitive Method for Detecting Peptide-specific CD4+ T Cell Responses in Peripheral Blood from Patients with Myasthenia Gravis;Frontiers in Immunology;2017-10-24

4. Predicting the effects of potentially therapeutic modified peptides on polyclonal T cell populations in a mouse model of multiple sclerosis;Journal of Neuroimmunology;2017-06

5. A CD4+T cell antagonist epitope down-regulates activating signaling proteins, up-regulates inhibitory signaling proteins and abrogates HIV-specific T cell function;Retrovirology;2014-07-05